2871:TSENichirei Corporation Analysis
Data as of 2026-06-23 - not real-time
¥2,103.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nichirei Corp (2871.T) is trading at ¥2,103.5, comfortably above its 20‑day SMA (¥1,983.5) and 50‑day SMA (¥1,925.1), while still below the 52‑week high of ¥2,178.5, indicating room for upside. Technical momentum is bullish with a MACD histogram of +6.79 and a bullish signal line, and the RSI sits at 65.5, suggesting strength without being overbought. The stock enjoys a stable volume profile and a low beta near zero, which dampens market‑wide volatility exposure, though the 30‑day price volatility is relatively high at ~26%. Fundamentally, revenue is growing at 6.7% YoY, margins are modest but stable, and the forward PE of 8.9 signals cheap valuation relative to earnings growth. The dividend payout ratio of 43% and a 2.45% yield appear sustainable given strong operating cash flow and a payout ratio below 50%. Analyst consensus is a “buy” with a median target price of ¥2,325, implying a modest upside of about 5% from current levels. The company’s diversified food, logistics, and bioscience operations in a consumer‑defensive sector provide resilience, while its Japanese base limits geopolitical risk. Overall, the blend of bullish technicals, reasonable valuation, and solid dividend sustainability supports a positive outlook.
Given the modest upside, low beta, and defensive industry positioning, the stock is best viewed as fairly valued with a slight undervaluation bias. The combination of stable cash generation, a healthy dividend, and analyst optimism makes it a compelling candidate for investors seeking steady returns with limited downside risk.
Given the modest upside, low beta, and defensive industry positioning, the stock is best viewed as fairly valued with a slight undervaluation bias. The combination of stable cash generation, a healthy dividend, and analyst optimism makes it a compelling candidate for investors seeking steady returns with limited downside risk.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and RSI indicating upward momentum
- Support level well below current price offering downside cushion
- Stable volume and low beta reducing short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus buy with median target price above current level
- Sustainable dividend yield and payout ratio
- Modest revenue growth and improving forward PE
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Defensive consumer sector providing resilience in economic cycles
- Diversified business lines across food, logistics, and bioscience
- Strong cash flow generation supporting dividend continuity
Key Metrics & Analysis
Financial Health
Revenue Growth6.70%
Profit Margin3.82%
P/E Ratio19.3
ROE9.94%
ROA4.61%
Debt/Equity40.98
P/B Ratio1.8
Op. Cash Flow¥48.7B
Free Cash Flow¥7.5B
Technical Analysis
TrendBullish
RSI65.5
Support¥1,775.50
Resistance¥2,178.50
MA 20¥1,983.48
MA 50¥1,925.09
MA 200¥1,888.70
MACDBullish
VolumeStable
Fear & Greed Index86
Valuation
Fair Value¥237.33
Target Price¥2,216.67
Upside/Downside5.38%
GradeFair
TypeBlend
Dividend Yield2.45%
Risk Assessment
Beta-0.05
Volatility25.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.